|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
5040178 |
| 003 |
ICU |
| 005 |
20041008104900.0 |
| 008 |
030620s2004 njua b 001 0 eng |
| 010 |
|
|
|a 2003014330
|
| 020 |
|
|
|a 0896039714 (alk. paper)
|
| 020 |
|
|
|a 1592594298 (e-ISBN)
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d NhCcYBP
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC271.G45
|b S85 2004
|
| 060 |
1 |
0 |
|a QZ 266
|b S948 2004
|
| 082 |
0 |
0 |
|a 616.99/4042
|2 21
|
| 245 |
0 |
0 |
|a Suicide gene therapy :
|b methods and reviews /
|c edited by Caroline J. Springer.
|
| 260 |
|
|
|a Totowa, N.J. :
|b Humana Press,
|c c2004.
|
| 300 |
|
|
|a xiv, 555 p. :
|b ill. (some col.) ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Methods in molecular medicine,
|x 1543-1894 ;
|v 90
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g 1.
|t Introduction to the Background, Principles, and State of the Art in Suicide Gene Therapy /
|r Ion Niculescu-Duvaz and Caroline J. Springer --
|g 2.
|t Introduction to Vectors for Suicide Gene Therapy /
|r Caroline J. Springer --
|g 3.
|t Construction of VNP20009: A Novel, Genetically Stable Antibiotic-Sensitive Strain of Tumor-Targeting Salmonella for Parenteral Administration in Humans /
|r Kenneth Brooks Low, Martina Ittensohn, Xiang Luo, Li-Mou Zheng, Ivan King, John M. Pawelek and David Bermudes --
|g 4.
|t Nonreplicating DNA Viral Vectors for Suicide Gene Therapy: The Adenoviral Vectors /
|r Masato Yamamoto and David T. Curiel --
|g 5.
|t Replication-Selective Oncolytic Adenoviruses /
|r Gunnel Hallden, Stephen H. Thorne, Jingping Yang and David H. Kirn --
|g 6.
|t Retroviral Vectors for Suicide Gene Therapy /
|r Colin Porter --
|g 7.
|t Nonviral Liposomes /
|r Andrew D. Miller --
|g 8.
|t Peptide- and Polymer-Based Gene Delivery Vehicles /
|r Richard Brokx and Jean Gariepy --
|g 9.
|t Design of Prodrugs for Suicide Gene Therapy /
|r Dan Niculescu-Duvaz, Ion Niculescu-Duvaz and Caroline J. Springer --
|g 10.
|t Cytochrome P450-Based Gene Therapies for Cancer /
|r E. Antonio Chiocca and David J. Waxman --
|g 11.
|t Tumor Sensitization to Purine Analogs by E. coli PNP /
|r Kimberly V. Curlee, William B. Parker and Eric J. Sorscher --
|g 12.
|t Enzyme-Prodrug Systems: Carboxylesterase/CPT-11 /
|r Mary K. Danks and Philip M. Potter --
|g 13.
|t Enzyme-Prodrug Systems: Thymidine Phosphorylase/5'-Deoxy-5-Fluorouridine /
|r Alexandre Evrard, Joseph Ciccolini, Pierre Cuq and Jean-Paul Cano --
|g 14.
|t Methods to Improve Efficacy in Suicide Gene Therapy Approaches: Targeting Prodrug-Activating Enzymes Carboxypeptidase G2 and Nitroreductase to Different Subcellular Compartments /
|r Silke Schepelmann, Robert Spooner, Frank Friedlos and Richard Marais --
|g 15.
|t Extracellular [beta]-Glucuronidase for Gene-Directed Enzyme-Prodrug Therapy /
|r Sabine Brusselbach --
|g 16.
|t Enhancement of Suicide Gene Prodrug Activation by Random Mutagenesis /
|r Jean-Emmanuel Kurtz and Margaret E. Black --
|g 17.
|t Combination Suicide Gene Therapy /
|r Wolfgang Uckert, Brian Salmons, Christian Beltinger, Walter H. Gunzburg and Thomas Kammertons --
|g 18.
|t Immune Response to Suicide Gene Therapy /
|r Shigeki Kuriyama, Hirohisa Tsujinoue and Hitoshi Yoshiji --
|g 19.
|t Targeting Cancer With Gene Therapy Using Hypoxia as a Stimulus /
|r Gabi U. Dachs, Olga Greco and Gillian M. Tozer --
|g 20.
|t Radiation-Activated Antitumor Vectors /
|r Simon D. Scott and Brian Marples --
|g 21.
|t In Vitro and In Vivo Models for the Evaluation of GDEPT: Quantifying Bystander Killing in Cell Cultures and Tumors /
|r William R. Wilson, Susan M. Pullen, Alison Hogg, Stephen M. Hobbs, Frederik B. Pruijn and Kevin O. Hicks --
|g 22.
|t Suicide Gene Therapy in Liver Tumors /
|r Long R. Jiao, Roman Havlik, Joanna Nicholls, Steen Lindkaer Jensen and Nagy A. Habib --
|g 23.
|t Clinical Trials With GDEPT: Cytosine Deaminase and 5-Fluorocytosine /
|r Nicola L. Brown and Nicholas R. Lemoine --
|g 24.
|t The Nitroreductase/CB 1954 Enzyme-Prodrug System /
|r Nicola K. Green, David J. Kerr, Vivien Mautner, Peter A. Harris and Peter F. Searle --
|g 25.
|t Side Effects of Suicide Gene Therapy /
|r Marjolijn M. van der Eb, Bertie de Leeuw, Alex J. van der Eb and Rob C. Hoeben --
|g 26.
|t Antibody-Directed Enzyme-Prodrug Therapy /
|r R. Barbara Pedley, Surinder K. Sharma, Robert E. Hawkins and Kerry A. Chester --
|g 27.
|t Bioreductive Prodrugs for Cancer Therapy /
|r Beatrice Seddon, Lloyd R. Kelland and Paul Workman.
|
| 650 |
|
0 |
|a Cancer
|x Gene therapy.
|0 http://id.loc.gov/authorities/subjects/sh92005201
|
| 650 |
1 |
2 |
|a Neoplasms
|x therapy.
|
| 650 |
2 |
2 |
|a Gene Therapy
|x methods.
|
| 650 |
|
7 |
|a Cancer
|x Gene therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845367
|
| 700 |
1 |
|
|a Springer, Caroline J.
|0 http://id.loc.gov/authorities/names/n2003129056
|1 http://viaf.org/viaf/75699709
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)52514368
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 84e3a267-7de4-53f8-a9c5-97103326ddeb
|s fbab0882-d70f-5e9d-ac42-eb4564b247ce
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.G45 S85 2004
|l JCL
|c JCL-Sci
|i 4796402
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.G45 S85 2004
|l JCL
|c JCL-Sci
|e MARO
|e CRERAR
|b 65309928
|i 7590579
|
